» Articles » PMID: 37761999

Association of Phosphorylated Pyruvate Dehydrogenase with Pyruvate Kinase M2 Promotes PKM2 Stability in Response to Insulin

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Sep 28
PMID 37761999
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin is a crucial signalling molecule that primarily functions to reduce blood glucose levels through cellular uptake of glucose. In addition to its role in glucose homeostasis, insulin has been shown to regulate cell proliferation. Specifically, insulin enhances the phosphorylation of pyruvate dehydrogenase E1α (PDHA1) at the Ser293 residue and promotes the proliferation of HepG2 hepatocellular carcinoma cells. Furthermore, we previously observed that p-Ser293 PDHA1 bound with pyruvate kinase M2 (PKM2) as confirmed by coimmunoprecipitation. In this study, we used an in silico analysis to predict the structural conformation of the two binding proteins. However, the function of the protein complex remained unclear. To investigate further, we treated cells with si-PDHA1 and si-PKM2, which led to a reduction in PKM2 and p-Ser293 PDHA1 levels, respectively. Additionally, we found that the PDHA S293A dephospho-mimic reduced PKM2 levels and its associated enzyme activity. Treatment with MG132 and leupeptin impeded the PDHA1 S293A-mediated PKM2 reduction. These results suggest that the association between p-PDHA1 and PKM2 promotes their stability and protects them from protein degradation. Of interest, we observed that p-PDHA1 and PKM2 were localized in the nucleus in liver cancer patients. Under insulin stimulation, the knockdown of both PDHA1 and PKM2 led to a reduction in the expression of common genes, including KDMB1. These findings suggest that p-PDHA1 and PKM2 play a regulatory role in these proteins' expression and induce tumorigenesis in response to insulin.

Citing Articles

Multi-omics Insights into PDHA1 as a Predictive Biomarker for Prognosis, Immunotherapy Efficacy, and Drug Sensitivity in Hepatocellular Carcinoma.

Pan Y, Zhang Y, Mao D, Fang Z, Ma Y, Jin D ACS Omega. 2024; 9(46):46492-46504.

PMID: 39583658 PMC: 11579764. DOI: 10.1021/acsomega.4c08010.

References
1.
Ren X, Schwartz M . Determination of GTP loading on Rho. Methods Enzymol. 2000; 325:264-72. DOI: 10.1016/s0076-6879(00)25448-7. View

2.
Kozakov D, Beglov D, Bohnuud T, Mottarella S, Xia B, Hall D . How good is automated protein docking?. Proteins. 2013; 81(12):2159-66. PMC: 3934018. DOI: 10.1002/prot.24403. View

3.
Swetha R, Ramaiah S, Anbarasu A . R521C and R521H mutations in FUS result in weak binding with Karyopherinβ2 leading to Amyotrophic lateral sclerosis: a molecular docking and dynamics study. J Biomol Struct Dyn. 2016; 35(10):2169-2185. DOI: 10.1080/07391102.2016.1209130. View

4.
Katz T, Vasilatos S, Harrington E, Oesterreich S, Davidson N, Huang Y . Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells. Breast Cancer Res Treat. 2014; 146(1):99-108. DOI: 10.1007/s10549-014-3012-9. View

5.
Lv W, Liu D, Liu X, Feng T, Li L, Qian B . Effects of PKM2 on global metabolic changes and prognosis in hepatocellular carcinoma: from gene expression to drug discovery. BMC Cancer. 2018; 18(1):1150. PMC: 6249977. DOI: 10.1186/s12885-018-5023-0. View